Skip to main content
Top
Published in: BMC Cancer 1/2018

Open Access 01-12-2018 | Research article

Characteristics and impact of the most-cited palliative oncology studies from 1995 to 2016

Authors: Corbin Eule, Nizar Bhulani, Elizabeth Paulk, Ramona Rhodes, Muhammad Shaalan Beg

Published in: BMC Cancer | Issue 1/2018

Login to get access

Abstract

Background

Palliative care, as a relatively young field within medicine, has increasingly used original research to validate and standardize its practice. In particular, palliative care has been incorporated into oncology to better address end-of-life decisions and care. The goal of this study is to identify seminal studies in the field of palliative oncology while more broadly characterizing the trends across the literature.

Methods

The publication databases Scopus and Web of Science were queried using predefined search terms to identify palliative oncology studies published between 1995 and 2016. The 100 most-cited articles from the time periods 1995–2005 and 2006–2016 were selected and analysed for publication data and study content.

Results

Palliative oncology studies were found to primarily examine patients with multiple rather than single cancer types and rarely were randomized controlled trials. Early research topics of pain, symptoms, and survival studies have been replaced by the issues of access to care, healthcare utilization, and religion and spirituality.

Conclusions

By identifying and analyzing notable studies in palliative oncology, we found areas of research that are commonly investigated or overlooked and identified model studies that highlight the need for additional disease-specific randomized control trials to provide high quality clinical evidence in the field.
Appendix
Available only for authorised users
Literature
1.
go back to reference Clark D. From margins to Centre: a review of the history of palliative care in cancer. The Lancet Oncology. 2007;8(5):430–8.CrossRef Clark D. From margins to Centre: a review of the history of palliative care in cancer. The Lancet Oncology. 2007;8(5):430–8.CrossRef
2.
go back to reference Loscalzo MJ. Palliative care: an historical perspective. Hematol Am Soc Hematol Educ Program. 2008;2008:465.CrossRef Loscalzo MJ. Palliative care: an historical perspective. Hematol Am Soc Hematol Educ Program. 2008;2008:465.CrossRef
3.
go back to reference Payne SA, Turner JM. Research methodologies in palliative care: a bibliometric analysis. Palliat Med. 2008;22(4):336–42.CrossRef Payne SA, Turner JM. Research methodologies in palliative care: a bibliometric analysis. Palliat Med. 2008;22(4):336–42.CrossRef
4.
go back to reference Tieman JJ, Abernethy A, Currow DC. Not published, not indexed: issues in generating and finding hospice and palliative care literature. J Palliat Med. 2010;13(6):669–75.CrossRef Tieman JJ, Abernethy A, Currow DC. Not published, not indexed: issues in generating and finding hospice and palliative care literature. J Palliat Med. 2010;13(6):669–75.CrossRef
5.
go back to reference Sepulveda C, Marlin A, Yoshida T, Ullrich A. Palliative Care the World Health Organization’s global perspective. J Pain Symptom Manage. 2002;24(2):91–6.CrossRef Sepulveda C, Marlin A, Yoshida T, Ullrich A. Palliative Care the World Health Organization’s global perspective. J Pain Symptom Manage. 2002;24(2):91–6.CrossRef
6.
go back to reference Mehta NJ, Khan IA, Mehta RN, Tejani F, Vasavada BC, Sacchi TJ. End-of-life care-related publications in cardiology journals. Am J Cardiol. 2001;88(12):1460–3 A1469.CrossRef Mehta NJ, Khan IA, Mehta RN, Tejani F, Vasavada BC, Sacchi TJ. End-of-life care-related publications in cardiology journals. Am J Cardiol. 2001;88(12):1460–3 A1469.CrossRef
7.
go back to reference Hui D, Parsons HA, Damani S, Fulton S, Liu J, Evans A, De La Cruz M, Bruera E. Quantity, design, and scope of the palliative oncology literature. Oncologist. 2011;16(5):694–703.CrossRef Hui D, Parsons HA, Damani S, Fulton S, Liu J, Evans A, De La Cruz M, Bruera E. Quantity, design, and scope of the palliative oncology literature. Oncologist. 2011;16(5):694–703.CrossRef
8.
go back to reference Sladek R, Tieman J, Fazekas BS, Abernethy AP, Currow DC. Development of a subject search filter to find information relevant to palliative care in the general medical literature. J Med Libr Assoc. 2006;94(4):394–401.PubMedPubMedCentral Sladek R, Tieman J, Fazekas BS, Abernethy AP, Currow DC. Development of a subject search filter to find information relevant to palliative care in the general medical literature. J Med Libr Assoc. 2006;94(4):394–401.PubMedPubMedCentral
9.
go back to reference United Nations DoEaSA, Population Division: World Population Prospects: The 2004 Revision. 2004.CrossRef United Nations DoEaSA, Population Division: World Population Prospects: The 2004 Revision. 2004.CrossRef
10.
go back to reference United Nations DoEaSA, Population Division: World Population Prospects: The 2015 Revision. 2015.CrossRef United Nations DoEaSA, Population Division: World Population Prospects: The 2015 Revision. 2015.CrossRef
11.
go back to reference Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.CrossRef Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray F. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–86.CrossRef
12.
go back to reference Services CfMM: CMS Finalizes 2016 Medicare Payment Rules for Physicians, Hospitals & Other Providers. 2015. Services CfMM: CMS Finalizes 2016 Medicare Payment Rules for Physicians, Hospitals & Other Providers. 2015.
13.
go back to reference Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer. 1997;80(7):1273–83.CrossRef Yancik R. Cancer burden in the aged: an epidemiologic and demographic overview. Cancer. 1997;80(7):1273–83.CrossRef
14.
go back to reference Grande GE, Todd CJ. Why are trials in palliative care so difficult? Palliat Med. 2000;14(1):69–74.CrossRef Grande GE, Todd CJ. Why are trials in palliative care so difficult? Palliat Med. 2000;14(1):69–74.CrossRef
15.
go back to reference Tieman J, Sladek R, Currow D. Changes in the quantity and level of evidence of palliative and hospice care literature: the last century. J Clin Oncol. 2008;26(35):5679–83.CrossRef Tieman J, Sladek R, Currow D. Changes in the quantity and level of evidence of palliative and hospice care literature: the last century. J Clin Oncol. 2008;26(35):5679–83.CrossRef
16.
go back to reference Seglen PO. Citation rates and journal impact factors are not suitable for evaluation of research. Acta Orthop Scand. 1998;69(3):224–9.CrossRef Seglen PO. Citation rates and journal impact factors are not suitable for evaluation of research. Acta Orthop Scand. 1998;69(3):224–9.CrossRef
17.
go back to reference Garfield E. Citation analysis as a tool in journal evaluation. Science. 1972;178(4060):471–9.CrossRef Garfield E. Citation analysis as a tool in journal evaluation. Science. 1972;178(4060):471–9.CrossRef
Metadata
Title
Characteristics and impact of the most-cited palliative oncology studies from 1995 to 2016
Authors
Corbin Eule
Nizar Bhulani
Elizabeth Paulk
Ramona Rhodes
Muhammad Shaalan Beg
Publication date
01-12-2018
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2018
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/s12885-018-5150-7

Other articles of this Issue 1/2018

BMC Cancer 1/2018 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine